|Articles|April 22, 2011
Enzymotec Signs Krill Deal with India Pharma Company
Enzymotec Ltd. has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.
Advertisement
Enzymotec Ltd. (Migdal HaEmek, Israel) has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.
Lupin is the world’s fifth largest pharmaceutical company, based on subscriptions, says Enzymotec.
A Krill Oil+ product will launch later this year in Indian markets.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New food app leverages AI to help consumers understand ingredients right from grocery aisle
2
How Aged Garlic Extract is Changing Men's Vitality
3
Greenvit joins the collagen ingredient market
4
SAI Gold level status received by Layn Natural ingredients for monk fruit
5
